U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H29N5O3
Molecular Weight 399.4867
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BMS-561388

SMILES

COCCN(CCOC)C1=NC(C)=NC2=C(C(C)=NN12)C3=CC=C(OC)C=C3C

InChI

InChIKey=DKAPUZDMFUBEBM-UHFFFAOYSA-N
InChI=1S/C21H29N5O3/c1-14-13-17(29-6)7-8-18(14)19-15(2)24-26-20(19)22-16(3)23-21(26)25(9-11-27-4)10-12-28-5/h7-8,13H,9-12H2,1-6H3

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist.
2011-06-23
Degradation pathways of a corticotropin-releasing factor antagonist in solution and solid states.
2009-08
Patents
Name Type Language
BMS 561388
Preferred Name English
BMS-561388
Code English
PYRAZOLO(1,5-A)-1,3,5-TRIAZIN-4-AMINE, N,N-BIS(2-METHOXYETHYL)-8-(4-METHOXY-2-METHYLPHENYL)-2,7-DIMETHYL-
Systematic Name English
N,N-BIS(2-METHOXYETHYL)-8-(4-METHOXY-2-METHYLPHENYL)-2,7-DIMETHYLPYRAZOLO(1,5-A)-1,3,5-TRIAZIN-4-AMINE
Systematic Name English
Code System Code Type Description
FDA UNII
7FC996ZZL5
Created by admin on Tue Apr 01 16:40:10 GMT 2025 , Edited by admin on Tue Apr 01 16:40:10 GMT 2025
PRIMARY
CAS
202578-88-9
Created by admin on Tue Apr 01 16:40:10 GMT 2025 , Edited by admin on Tue Apr 01 16:40:10 GMT 2025
PRIMARY
PUBCHEM
9908904
Created by admin on Tue Apr 01 16:40:10 GMT 2025 , Edited by admin on Tue Apr 01 16:40:10 GMT 2025
PRIMARY